Brimonidine Related Impurity 3 (135306-56-8)
| Identification |
| Properties |
| Safety Data |
| |
 |
Other Product
- Fesoterodine Related Impurity 2
- Ceftibuten Related Impurity 9
- Brimonidine
- O-Ethyl (5-BroMoquinoxalin-6-yl)carbaMothioate (BriMonidine IMpurity)
- Atorvastatin Related Compound C (20 mg) (Difluoro impurity,
or (3R,5R)-7-[3-(phenylcarbamoyl)-4,5-bis(4-fluorophenyl)-
2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid
calcium salt)
- Atorvastatin Related Compound A (20 mg) (Desfluoro impurity,
or (3R,5R)-7-[3-(phenylcarbamoyl)-2-isopropyl-4,5-
diphenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid
calcium salt)
- Lubiprostone Related Compound 3
- Fasudil IMpurity 3
- Decitabine iMpurity 3
- TriMethopriM iMpurity 3
- Sitagliptin Defuoro IMpurity 3
- Milrinone IMpurity 3
- Vortioxetine Impurity 3
- Brimonidine D-tartrate
- Brimonidine D-tartrate
- 4,5-Didehydro BriMonidine
- BriMonidine-2,3-dione
- Desogestrel Related Compound (3-alpha-Hydroxy Desogestrel)
- Cetirizine 3-Chloro IMpurity Dihydrochloride
- 3-(1,2-Benzisothiazolyl) Ziprasidone
(Ziprasidone Impurity E)
